Alberto Bardelli Lab

Medical research: Personalized test tracks cancer relapse
Bardelli A.
Nature. 2017 May 24;545(7655):417-418. doi: 10.1038/545417a. No abstract available. PMID: 28541318

Integrating liquid biopsies in the management of cancer
Siravegna G, Marsoni S, Siena S, Bardelli A
Nature Reviews Clinical Oncology. 2017 Mar 2. doi: 10.1038/nrclinonc.2017.14. [Epub ahead of print]

Liquid biopsies, what we do not know (yet)
Bardelli A, Pantel K
Cancer Cell. 2017 Cancer Cell. 2017 Feb 13;31(2):172-179

Acquired resistance to the TRK inhibitor entrectinib in colorectal cancer
Russo M, Misale S, Wei G, Siravegna G, Crisafulli G, Lazzari L, Corti G, Rospo G, Novara L, Mussolin B, Bartolini A, Cam N, Patel R, Yan S, Shoemaker R, Wild R, Di Nicolantonio F, Sartore Bianchi A, Li G, Siena S, Bardelli A
Cancer Discov. 2016 Jan;6(1):36-44

Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer.
Van Emburgh BO, Arena S, Siravegna G, Lazzari L, Crisafulli G, Corti G, Mussolin B, Baldi F, Buscarino M, Bartolini A, Valtorta E, Vidal J, Bellosillo B, Germano G, Pietrantonio F, Ponzetti A, Albanell J, Siena S, Sartore-Bianchi A, Di Nicolantonio F, Montagut C, Bardelli A
Nat Commun. 2016 Dec 8;7:13665.

Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
Siravegna G, Mussolin B, Buscarino M, Corti G, Cassingena A, Crisafulli G, Ponzetti A, Cremolini C, Amatu A, Lauricella C, Lamba S, Hobor S, Avallone A, Valtorta E, Rospo G, Medico E, Motta V, Antoniotti C, Tatangelo F, Bellosillo B, Veronese S, Budillon A, Montagut C, Racca P, Marsoni S, Falcone A, Corcoran RB, Di Nicolantonio F, Loupakis F, Siena S, Sartore-Bianchi A, Bardelli A
Nat Med. 2015 Jul;21(7):795-801